[Chronic myeloid leukemia 2008].
作者信息
Cervantes Francisco
出版信息
Med Clin (Barc). 2008 Nov 15;131(17):658-9. doi: 10.1157/13128730.
DOI:10.1157/13128730
PMID:19087793
Abstract
摘要
相似文献
1
[Chronic myeloid leukemia 2008].[慢性髓性白血病2008年]
Med Clin (Barc). 2008 Nov 15;131(17):658-9. doi: 10.1157/13128730.
2
[Management of chronic myeloid leukemia].[慢性髓性白血病的管理]
Rinsho Ketsueki. 2008 Oct;49(10):1401-10.
3
Dasatinib for the treatment of Philadelphia chromosome-positive leukaemias.达沙替尼用于治疗费城染色体阳性白血病。
Expert Opin Investig Drugs. 2007 May;16(5):679-87. doi: 10.1517/13543784.16.5.679.
4
[Management of advanced stage chronic myeloid leukemia].[晚期慢性髓性白血病的管理]
Rinsho Ketsueki. 2014 Oct;55(10):1860-9.
5
Hematology: Nilotinib and dasatinib--new 'magic bullets' for CML?血液学：尼洛替尼和达沙替尼——慢性粒细胞白血病的新型“神奇子弹”？
Nat Rev Clin Oncol. 2010 Oct;7(10):557-8. doi: 10.1038/nrclinonc.2010.151.
6
[Molecular targeting therapy for chronic myeloid leukemia].[慢性髓性白血病的分子靶向治疗]
Rinsho Ketsueki. 2007 Jan;48(1):46-55.
7
[TKI therapy for CML].[慢性粒细胞白血病的酪氨酸激酶抑制剂治疗]
Rinsho Ketsueki. 2011 Jul;52(7):452-9.
8
Second generation tyrosine kinase inhibitors for the treatment of chronic myelogenous leukemia. [An interview with Hagop Katarjian by H&O].用于治疗慢性粒细胞白血病的第二代酪氨酸激酶抑制剂。[H&O对哈戈普·卡塔吉安的采访]
Clin Adv Hematol Oncol. 2008 Nov;6(11):797-9.
9
Dasatinib for the treatment of Philadelphia chromosome-positive chronic myelogenous leukaemia after imatinib failure.达沙替尼用于治疗伊马替尼治疗失败后的费城染色体阳性慢性髓性白血病。
Expert Opin Pharmacother. 2007 Dec;8(18):3257-64. doi: 10.1517/14656566.8.18.3257.
10
10 years of progress in chronic myelogenous leukemia.慢性粒细胞白血病十年进展
J Natl Compr Canc Netw. 2012 Sep;10(9):1049-53. doi: 10.6004/jnccn.2012.0110.
Zotero 插件